Patel P - Search Results

1

Targeting c-Met in Cancer Therapy: Unravelling Structure-Activity Relationships and Docking Insights for Enhanced Anticancer Drug Design.

Singh S, Nigam V, Kasana S, Kurmi BD, Gupta GD, Patel P. Singh S, et al. Among authors: patel p. Curr Top Med Chem. 2024 Oct 31. doi: 10.2174/0115680266331025241015084546. Online ahead of print. Curr Top Med Chem. 2024. PMID: 39484763

2

Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches.

Asati V, Anant A, Patel P, Kaur K, Gupta GD. Asati V, et al. Among authors: patel p. Eur J Med Chem. 2021 Dec 5;225:113781. doi: 10.1016/j.ejmech.2021.113781. Epub 2021 Aug 18. Eur J Med Chem. 2021. PMID: 34438126 Review.

3

Recent Progress in Histone Deacetylase (HDAC) 1 Inhibitors as Anticancer Agent.

Patel P, Wahan SK, Vishakha S, Kurmi BD, Gupta GD, Rajak H, Asati V. Patel P, et al. Curr Cancer Drug Targets. 2022;23(1):47-70. doi: 10.2174/1568009622666220624090542. Curr Cancer Drug Targets. 2022. PMID: 35747969 Review.

4

Solid Lipid Nanoparticles (SLNs): Advancements in Modification Strategies Toward Drug Delivery Vehicle.

Al-Sayadi GMH, Verma A, Choudhary Y, Sandal P, Patel P, Singh D, Gupta GD, Kurmi BD. Al-Sayadi GMH, et al. Among authors: patel p. Pharm Nanotechnol. 2023;11(2):138-154. doi: 10.2174/2211738511666221026163303. Pharm Nanotechnol. 2023. PMID: 36305142 Review.

5

Hydroxamic acid derivatives as selective HDAC3 inhibitors: computer-aided drug design strategies.

Patel P, Shrivastava SK, Sharma P, Kurmi BD, Shirbhate E, Rajak H. Patel P, et al. J Biomol Struct Dyn. 2024 Jan-Feb;42(1):362-383. doi: 10.1080/07391102.2023.2192804. Epub 2023 Mar 30. J Biomol Struct Dyn. 2024. PMID: 36995068

6

Validation of a Novel Supercritical Fluid Extractor/Dryer Combo Instrument.

Kumar M, Sharma Y, Chahar K, Kumari L, Mishra L, Patel P, Singh D, Kurmi BD. Kumar M, et al. Among authors: patel p. Assay Drug Dev Technol. 2023 Apr;21(3):126-136. doi: 10.1089/adt.2023.005. Epub 2023 Mar 30. Assay Drug Dev Technol. 2023. PMID: 36999897 Review.

7

Current Medicinal Insights on Synthetic Small Molecules and Natural Origin Products as PD-1/PD-L1 Inhibitors.

Pandey S, Kurmi BD, Patel P. Pandey S, et al. Among authors: patel p. Curr Top Med Chem. 2023;23(18):1765-1781. doi: 10.2174/1568026623666230417111616. Curr Top Med Chem. 2023. PMID: 37070445 Review.

8

Doxorubicin Conjugates: An Efficient Approach for Enhanced Therapeutic Efficacy with Reduced Side Effects.

Sandal P, Kumari L, Patel P, Singh A, Singh D, Gupta GD, Kurmi BD. Sandal P, et al. Among authors: patel p. Assay Drug Dev Technol. 2023 May-Jun;21(4):137-156. doi: 10.1089/adt.2022.102. Epub 2023 Apr 20. Assay Drug Dev Technol. 2023. PMID: 37083490 Review.

9

A Mini-review on New Developments in Nanocarriers and Polymers for Ophthalmic Drug Delivery Strategies.

Sharma Y, Patel P, Kurmi BD. Sharma Y, et al. Among authors: patel p. Curr Drug Deliv. 2024;21(4):488-508. doi: 10.2174/1567201820666230504115446. Curr Drug Deliv. 2024. PMID: 37143264 Review.

10

Current progress in the targeted therapy of breast cancer: Structure-activity correlation and docking studies (2015-2021).

Pandey S, Mondal S, Kajal K, Kurmi BD, Verma SK, Patel P. Pandey S, et al. Among authors: patel p. Arch Pharm (Weinheim). 2023 Aug;356(8):e2200602. doi: 10.1002/ardp.202200602. Epub 2023 May 21. Arch Pharm (Weinheim). 2023. PMID: 37211680 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,055 results

Search Page

Filters